Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
Status:
Completed
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Donor site pain study comparing post-operative donor site pain and opioid consumption after
use of Lidocaine or Liposomal Bupivicaine for split thickness skin graft harvesting in
patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness
burn wounds.